Exclusivity Patents and exclusivity Drug Information Prescribing and other information DMFs Type 2 master files Databases Free access to database search 21 CFR FDA regulations for this API Federal Register FR search results for this API Drug Recalls For Rx's using this API

FDA Approval Activities for this Drug… Azulfidine EN-tabs (sulfasalazine) Tablets, 500 mg, Pharmacia & Upjohn NDA 21-243 8/18/00 7/18/01 7/18/01 7/18/01 Azulfidine Indications: for the treatment of pediatric patients with polyarticular course juvenile rheumatoid arthritis who have responded inadequately to salicylates or other nonsteroidal anti-inflammatory drugs. Azulfidine EN-tabs (sulfasalazine) Tablets, 500 mg, Pharmacia & Upjohn NDA 7-073/S-120 7/30/02 8/6/02 Azulfidine EN-tabs (sulfasalazine) Tablets, 500 mg, Pharmacia & Upjohn NDA 7-073/S-115 Sulfasalazine Delayed-Release Tablets, 500 mg, Sulfasalazine Delayed-Release Tablets, Vintage ANDA 75-339 1/11/02 Sulfasalazine Tablets, 500 mg, Vintage ANDA 40-349 SULFASALAZINE Suspension; 250MG/5ML AZULFIDINE PHARMACIA AND UPJOHN 007073 SULFASALAZINE Tablet, Delayed Release; 500MG AZULFIDINE EN-TABS PHARMACIA AND UPJOHN 075339 SULFASALAZINE Tablet, Delayed Release; 500MG SULFASALAZINE Vintage 089590 SULFASALAZINE Tablet; 500MG SULFASALAZINE Mutual 007073 SULFASALAZINE Tablet; 500MG AZULFIDINE PHARMACIA AND UPJOHN 040349 SULFASALAZINE Tablet; 500MG SULFASALAZINE Vintage 085828 SULFASALAZINE Tablet; 500MG SULFASALAZINE Watson 087197 SULFASALAZINE Tablet; 500MG SULFASALAZINE Watson Check the most up-to-date list of FDA Approvals.   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | FindingHealthOnline © 2008 Betterchem Corp.